SCHEMBL7215331

SCHEMBL7215331

CCn1c(=O)[nH]c2cnc(-c3ccccc3)nc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.68
USP1 O94782 15/20 0.55
CYP1A2 P05177 2/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ADORA2B P29275 1/20 0.46
GABRP O00591 1/20 0.45
GABRD O14764 1/20 0.45
GABRA1 P14867 1/20 0.45
GABRB1 P18505 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA5 P31644 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
GABRA4 P48169 1/20 0.45
GABRE P78334 1/20 0.45
GABRA6 Q16445 1/20 0.45
GABRG1 Q8N1C3 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7210956 0.90 ADORA3 (0.65) ADORA3USP1CYP1A2MEN1KMT2A
SCHEMBL7210910 0.86 ADORA3 (0.84) ADORA3USP1
SCHEMBL2210780 0.84 ADORA3 (0.62) ADORA3USP1
SCHEMBL7212031 0.82 ADORA3 (0.58) ADORA3USP1MEN1KMT2AADORA2B
SCHEMBL7215568 0.81 ADORA3 (0.55) ADORA3USP1
SCHEMBL4147487 0.79 ADORA3 (0.56) ADORA3USP1
SCHEMBL27887734 0.78 TSPO (0.56) ADORA3USP1
SCHEMBL24765254 0.76 ADORA2A (0.48) ADORA3USP1CYP1A2MEN1KMT2A
SCHEMBL12639129 0.73 PDE4A (0.42) ADORA3USP1CYP1A2MEN1KMT2A
SCHEMBL4050226 0.73 ADORA3 (0.49) ADORA3USP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1036794-B1 2-ARYL-8-OXODIHYDROPURINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME, AND INTERMEDIATES THEREOF DAINIPPON PHARMACEUTICAL CO (JP) 2003-08-27 EP disclosed
US-6372740-B1 NERVOUS SYSTEM DISORDERS, ANTIEPILEPTIC AGENTS AND ANTIDEPRESSANTS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2002-04-16 US disclosed
EP-1036794-A1 2-ARYL-8-OXODIHYDROPURINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME, AND INTERMEDIATES THEREOF Dainippon Pharmaceutical Co., Ltd. (JP) 2000-09-20 EP disclosed